molecular function |
| GO:0001664 | | G-protein coupled receptor binding | | Interacting selectively and non-covalently with a G-protein coupled receptor. |
| GO:0031768 | | ghrelin receptor binding | | Interacting selectively and non-covalently with a ghrelin receptor. |
| GO:0016608 | | growth hormone-releasing hormone activity | | The action characteristic of growth hormone-releasing hormone, any of a family of peptide hormones that act on the anterior pituitary to stimulate the secretion of growth hormone and exert a trophic effect on the gland. |
| GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| GO:0030296 | | protein tyrosine kinase activator activity | | Increases the activity of a protein tyrosine kinase, an enzyme which phosphorylates a tyrosyl phenolic group on a protein. |
biological process |
| GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| GO:0008154 | | actin polymerization or depolymerization | | Assembly or disassembly of actin filaments by the addition or removal of actin monomers from a filament. |
| GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| GO:0008343 | | adult feeding behavior | | Feeding behavior in a fully developed and mature organism. |
| GO:0046697 | | decidualization | | The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta. |
| GO:0016358 | | dendrite development | | The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure. A dendrite is a freely branching protoplasmic process of a nerve cell. |
| GO:0060079 | | excitatory postsynaptic potential | | A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. |
| GO:0001696 | | gastric acid secretion | | The regulated release of gastric acid (hydrochloric acid) by parietal or oxyntic cells during digestion. |
| GO:0009755 | | hormone-mediated signaling pathway | | A series of molecular signals mediated by the detection of a hormone. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0042322 | | negative regulation of circadian sleep/wake cycle, REM sleep | | Any process that stops, prevents or reduces the duration or quality of rapid eye movement (REM) sleep. |
| GO:0001937 | | negative regulation of endothelial cell proliferation | | Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation. |
| GO:2000506 | | negative regulation of energy homeostasis | | Any process that stops, prevents or reduces the frequency, rate or extent of energy homeostasis. |
| GO:0050728 | | negative regulation of inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
| GO:0046676 | | negative regulation of insulin secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. |
| GO:0032691 | | negative regulation of interleukin-1 beta production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production. |
| GO:0045409 | | negative regulation of interleukin-6 biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6. |
| GO:0040013 | | negative regulation of locomotion | | Any process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism. |
| GO:0042536 | | negative regulation of tumor necrosis factor biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis. |
| GO:0032100 | | positive regulation of appetite | | Any process that increases appetite. |
| GO:0046010 | | positive regulation of circadian sleep/wake cycle, non-REM sleep | | Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep. |
| GO:0051461 | | positive regulation of corticotropin secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of corticotropin hormone from a cell. |
| GO:0051464 | | positive regulation of cortisol secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of cortisol from a cell. |
| GO:0007204 | | positive regulation of cytosolic calcium ion concentration | | Any process that increases the concentration of calcium ions in the cytosol. |
| GO:2000507 | | positive regulation of energy homeostasis | | Any process that activates or increases the frequency, rate or extent of energy homeostasis. |
| GO:0060124 | | positive regulation of growth hormone secretion | | Any process that increases the frequency, rate or extent of the regulated release of growth hormone from a cell. |
| GO:0032024 | | positive regulation of insulin secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of insulin. |
| GO:0061098 | | positive regulation of protein tyrosine kinase activity | | Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity. |
| GO:0032097 | | positive regulation of response to food | | Any process that activates, maintains, or increases the rate of a response to a food stimulus. |
| GO:0051965 | | positive regulation of synapse assembly | | Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse. |
| GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| GO:0032095 | | regulation of response to food | | Any process that modulates the frequency, rate or extent of a response to a food stimulus. |
| GO:0043627 | | response to estrogen | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
| GO:0009725 | | response to hormone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
| GO:0008542 | | visual learning | | Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue. |
cellular component |
| GO:0030424 | | axon | | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0098794 | | postsynapse | | The part of a synapse that is part of the post-synaptic cell. |